Sajid, S., Mann, J. J., & Grunebaum, M. F. (2025). Clinical trials since 2020 of rapid anti-suicidal ideation effects of ketamine and its enantiomers: a systematic review. Translational Psychiatry, 15(1). https://doi.org/10.1038/s41398-025-03255-0

How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety? (2024). AMA Journal of Ethics, 26(11), E868-874. https://doi.org/10.1001/amajethics.2024.868

Bulthuis, N. E., McGowan, J. C., Ladner, L. R., LaGamma, C. T., Lim, S. C., Shubeck, C. X., Brachman, R. A., Sydnor, E., Pavlova, I. P., Seo, D., Drew, M. R., & Denny, C. A. (2024). GluN2B on Adult-Born Granule Cells Modulates (R,S)-Ketamine’s Rapid-Acting Effects in Mice. International Journal of Neuropsychopharmacology, 27(10). https://doi.org/10.1093/ijnp/pyae036

Wunsch, H., Bosch, N. A., Law, A. C., Vail, E. A., Hua, M., Shen, B. H., Lindenauer, P. K., Juurlink, D. N., Walkey, A. J., & Gershengorn, H. B. (2024). Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients. American Journal of Respiratory and Critical Care Medicine, 210(10), 1243–1251. https://doi.org/10.1164/rccm.202404-0813oc

Yasin, B., Williams, D. J., Troyas, C., Harrison, N. L., Makinson, C. D., & García, P. S. (2024). Ketamine Potentiates AMPA Receptor-mediated Activity in the Somatosensory Cortex. Anesthesiology, 141(3), 611–614. https://doi.org/10.1097/aln.0000000000005108

Ribeiro, F. C., Cozachenco, D., Argyrousi, E. K., Staniszewski, A., Wiebe, S., Calixtro, J. D., Soares‐Neto, R., Al‐Chami, A., Sayegh, F. E., Bermudez, S., Arsenault, E., Cossenza, M., Lacaille, J., Nader, K., Sun, H., De Felice, F. G., Lourenco, M. V., Arancio, O., Aguilar‐Valles, A., … Ferreira, S. T. (2024). The ketamine metabolite (2R,6R)‐hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer’s disease. Alzheimer’s & Dementia, 20(8), 5398–5410. Portico. https://doi.org/10.1002/alz.14034

Sajid, S., Galfalvy, H. C., Keilp, J. G., Burke, A. K., Mann, J. J., & Grunebaum, M. F. (2024). Acute Dissociation and Ketamine’s Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial. International Journal of Neuropsychopharmacology, 27(4). https://doi.org/10.1093/ijnp/pyae017

McGowan, J. C., Ladner, L. R., Shubeck, C. X., Tapia, J., LaGamma, C. T., Anqueira-González, A., DeFrancesco, A., Chen, B. K., Hunsberger, H. C., Sydnor, E. J., Logan, R. W., Yu, T.-S., Kernie, S. G., & Denny, C. A. (2024). Traumatic Brain Injury–Induced Fear Generalization in Mice Involves Hippocampal Memory Trace Dysfunction and Is Alleviated by (R,S)-Ketamine. Biological Psychiatry, 95(1), 15–26. https://doi.org/10.1016/j.biopsych.2023.06.030

Palamar, J. J., Wilkinson, S. T., Carr, T. H., Rutherford, C., & Cottler, L. B. (2023). Trends in Illicit Ketamine Seizures in the US From 2017 to 2022. JAMA Psychiatry, 80(7), 750. https://doi.org/10.1001/jamapsychiatry.2023.1423

Vanderschelden, B., Gebara, M. A., Oughli, H. A., Butters, M. A., Brown, P. J., Farber, N. B., Flint, A. J., Karp, J. F., Lavretsky, H., Mulsant, B. H., Reynolds, C. F., Roose, S. P., & Lenze, E. J. (2023). Change in patient‐centered outcomes of psychological well‐being, sleep, and suicidality following treatment with intravenous ketamine for late‐life treatment‐resistant depression. International Journal of Geriatric Psychiatry, 38(7). Portico. https://doi.org/10.1002/gps.5964

Oughli, H. A., Gebara, M. A., Ciarleglio, A., Lavretsky, H., Brown, P. J., Flint, A. J., Farber, N. B., Karp, J. F., Mulsant, B. H., Reynolds, C. F., Roose, S. P., Yang, L., Butters, M. A., & Lenze, E. J. (2023). Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition. The American Journal of Geriatric Psychiatry, 31(3), 210–221. https://doi.org/10.1016/j.jagp.2022.11.013

Chen, B. K., & Denny, C. A. (2023). Weapons of stress reduction: (R,S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders. Neuropharmacology, 224, 109345. https://doi.org/10.1016/j.neuropharm.2022.109345

Bloomfield-Clagett, B., Ballard, E. D., Greenstein, D. K., Wilkinson, S. T., Grunebaum, M. F., Murrough, J. W., Mathew, S. J., Phillips, J. L., Fava, M., Sanacora, G., & Zarate, C. A. (2022). A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. International Journal of Neuropsychopharmacology, 25(10), 827–838. https://doi.org/10.1093/ijnp/pyac055

Barreto Chang, O. L., Kreuzer, M., Morgen, D. F., Possin, K. L., & García, P. S. (2022). Ketamine Associated Intraoperative Electroencephalographic Signatures of Elderly Patients With and Without Preoperative Cognitive Impairment. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000005875

Medeiros, G. C., Gould, T. D., Prueitt, W. L., Nanavati, J., Grunebaum, M. F., Farber, N. B., Singh, B., Selvaraj, S., Machado-Vieira, R., Achtyes, E. D., Parikh, S. V., Frye, M. A., Zarate, C. A., & Goes, F. S. (2022). Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis. Molecular Psychiatry, 27(9), 3658–3669. https://doi.org/10.1038/s41380-022-01652-1

Mastrodonato, A., Pavlova, I., Kee, N. C., Pham, V. A., McGowan, J. C., Mann, J. J., & Denny, C. A. (2022). Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice. International Journal of Neuropsychopharmacology, 25(6), 512–523. https://doi.org/10.1093/ijnp/pyac020

Hochschild, A., Keilp, J. G., Madden, S. P., Burke, A. K., Mann, J. J., & Grunebaum, M. F. (2022). Ketamine vs midazolam: Mood improvement reduces suicidal ideation in depression. Journal of Affective Disorders, 300, 10–16. https://doi.org/10.1016/j.jad.2021.12.055